Tocilizumab (Actemra)
Tocilizumab (Actemra) is a biologic medication approved to treat adults with moderately to severely active rheumatoid (RA), adults with giant cell arteritis (GCA), and people ages 2 and above with polyarticular juvenile idiopathic arthritis (PJIA) or systemic juvenile idiopathic arthritis (SJIA).
